Barry, Meagan A <br/><br/>
A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  04 2016 
 - 976-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.1080/21645515.2015.1119346  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Animals<br/>Antibodies, Protozoan--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Chagas Cardiomyopathy--therapy<br/>Chagas Disease--immunology<br/>Disease Models, Animal<br/>Female<br/>Heart--parasitology<br/>Immunity, Cellular<br/>Immunoglobulin G--biosynthesis<br/>Immunotherapy--methods<br/>Interferon-gamma--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Nanoparticles<br/>Oligodeoxyribonucleotides--immunology<br/>Parasitemia--therapy<br/>Protozoan Vaccines--immunology<br/>Th1 Cells--immunology<br/>Trypanosoma cruzi--immunology<br/>Vaccines, DNA--adverse effects